Grail (GRAL) 股價低於 70 美元，現在是該買入、賣出還是持有？
· finance.yahoo.com
這家研發血液癌症檢測技術的開發商，前景依然看好。
Grail (NASDAQ: GRAL), which was spun off from Illumina (NASDAQ: ILMN) in 2024, reached a record high of $116.06 on Jan. 22. But today, the cancer test developer...
· finance.yahoo.com
這家研發血液癌症檢測技術的開發商，前景依然看好。
Grail (NASDAQ: GRAL), which was spun off from Illumina (NASDAQ: ILMN) in 2024, reached a record high of $116.06 on Jan. 22. But today, the cancer test developer...
More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI